Every patient at our Northeast Frisco clinic receives a personalized evaluation
These effects lead to decreased blood glucose levels, facilitating euglycemia
Understanding your FTO rs9939609 variant, MC4R rs17782313 status, and GLP1R genetic profile informs whether your provider should anticipate robust early responses, gradual improvements, or potential plateaus
FDA approval for a new indication for Wegovy (semaglutide) to reduce the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke, in adults with cardiovascular disease and obesity or overweight
Understanding these effects is important, as weight changes can be a concern for many people